Navigation Links
KICVentures Ramps Up AxioMed Freedom Cervical Disc Manufacturing to Meet OUS Orders and Expand Market Share Rapidly
Date:12/27/2018

AxioMed completed its initial production of the first 60 cervical discs for implantation at its new Boston facility, and is now raising growth capital to ramp up demand for orders already placed, and to have additional inventory to immediately expand market share against inferior ball and socket discs. The capital raise is targeted to qualified private investors with a $50,000 minimum per investor. This sum encourages more participation vs. institutions with deeper pockets because Dr. Chin, Managing Partner and CEO of KICVentures (AxioMed's parent company) believes this disc should have a grass roots success story.

About AxioMed LLC

AxioMed was founded to advance the standard of care for patients with degenerative spine conditions by progressing spine technology beyond fusion and first-generation artificial discs. Led by an experienced surgeon team and utilizing patented viscoelastic polymer technology, AxioMed has developed the next generation of artificial discs. AxioMed completed its U.S. IDE for the Lumbar Disc with over five years of clinical follow-up.

About KICVentures

KICVentures is a private investment company founded in 2005 by Harvard-trained Orthopedic Surgeon & Professor Dr. Kingsley R. Chin, who brings unique experience at the intersection of medicine, business and information technology. KICVentures is equipped with a strong advantage in identifying niche healthcare opportunities, and is headquartered in Boston, Mass.

Read the full story at https://www.prweb.com/releases/kicventures_ramps_up_axiomed_freedom_cervical_disc_manufacturing_to_meet_ous_orders_and_expand_market_share_rapidly/prweb15997208.htm.


'/>"/>
Source: PRWeb
Copyright©2018 Vocus, Inc.
All rights reserved


Related biology news :

1. DFG and Leopoldina: Recommendations on scientific freedom and scientific responsibility
2. Genetic circuit allows both individual freedom, collective good
3. Study shows Hera Therapeutics compound combats HPV types that cause most cervical cancer
4. Clearing cells to prevent cervical cancer
5. Current guidelines underestimate US cervical cancer incidence and older womens risk
6. Radiation therapy for cervical cancer increases risk for colorectal cancer
7. LSUHSC research reveals structure of master regulator and new drug target for autism, cervical cancer
8. International team completes systematic, genomic study of cervical cancer
9. Biocompare Releases Documentary on “What Researchers Need to Know about Antibody Manufacturing”
10. RoosterBio Inc. and Tissue Regeneration Therapeutics Inc. Announce Alliance Around Scale-up Manufacturing of Umbilical Cord Tissue Perivascular Cell Technology
11. ACEA Biosciences Joins Cell Manufacturing Research Initiative to Further Advance Cell Therapy Discovery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/9/2019)... ... March 08, 2019 , ... Ace ... product, Well-Mints™ resveratrol + ribose hard candy lozenges ( http://www.well-mints.com ). , Well-Mints™ ... naturally flavored hard candy base dusted with powdered sugar. , Well-Mints'™ patented technology ...
(Date:3/1/2019)... (PRWEB) , ... February 28, 2019 , ... Teresa Krabbe, ... der Isar of the Technical University Munich, has been awarded an xCELLigence Research Grant ... an improved oncolytic virus platform. , Oncolytic viruses represent an exciting new ...
(Date:2/22/2019)... ... 2019 , ... RoosterBio, Inc, a privately held regenerative medicine ... Frederick, MD after a year of rapid growth. , “Hundreds of researchers and ... products to streamline their product development efforts in the regenerative medicine field, resulting ...
Breaking Biology News(10 mins):
(Date:3/14/2019)... ... March 14, 2019 , ... Xybion ... research organizations. It is a low code, GDPR/21 CFR Part 11-compliant digital ... technology-driven automated data capture and seamless data and information management. , ...
(Date:3/11/2019)... ... ... In this live webinar, the featured speakers will focus on the many attributes that ... how to use the information they have from the protocol and clinical trial knowledge, ... is properly designed and set up to ensure flawless execution. As clinical trial success ...
(Date:3/9/2019)... SEATTLE (PRWEB) , ... March ... ... source for unbiased college rankings and higher education planning, announced the release ... identifies the top programs in the nation based on curriculum quality, program ...
(Date:3/4/2019)... ... ... of current hot topics through free webinars presented by leading experts in pharma, biotech, medical ... today to save your place! Participate in the discussion and stay relevant in your field! ... , March 20 – Implementing BYOD Across Phase II and III Clinical Trials ...
Breaking Biology Technology: